Elanco Animal Health Incorporated Payments for Software
Elanco Animal Health Incorporated (ELAN) reported Payments for Software of $4.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForSoftware · last filed 2023-05-09
- Elanco Animal Health Incorporated payments for software for the quarter ending 2023-03-31 was $4.00M, a 42.86% decline year-over-year.
- Elanco Animal Health Incorporated payments for software for the quarter ending 2022-09-30 was $10.00M.
- Elanco Animal Health Incorporated payments for software for the quarter ending 2022-06-30 was $6.00M, a 14.29% decline year-over-year.
- Elanco Animal Health Incorporated payments for software for the quarter ending 2022-03-31 was $7.00M, a 40.00% increase year-over-year.
| Period end | Payments for Software 3 month | Payments for Software 3 month as first filed | Payments for Software 6 month | Payments for Software 6 month as first filed | Payments for Software 9 month | Payments for Software 9 month as first filed |
|---|---|---|---|---|---|---|
| 2023-03-31 | $4.00M 10-Q · filed 2023-05-09 | |||||
| 2022-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $16.00M derived: sum of 2 quarters · filed 2022-11-08 | $23.00M 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $13.00M 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | $7.00M 10-Q · filed 2023-05-09 | |||||
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $6.00M derived: sum of 2 quarters · filed 2022-11-08 | $11.00M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $12.00M 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-09 | |||||
| 2020-09-30 | $88.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $116.00M derived: sum of 2 quarters · filed 2021-11-05 | $148.00M 10-Q · filed 2021-11-05 | $147.80M 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $60.00M 10-Q · filed 2021-08-09 | $59.60M 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | $32.00M 10-Q · filed 2021-05-07 | $31.80M 10-Q · filed 2020-05-07 | ||||
| 2019-09-30 | $13.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $33.70M derived: sum of 2 quarters · filed 2020-11-06 | $36.20M 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $20.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $22.90M 10-Q · filed 2020-07-30 | ||||
| 2019-03-31 | $2.50M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |